Evaluating antioxidant treatment approaches for eosinophilic chronic sinusitis
Takeshi Kusunoki1, Davis Joseph2,3,4, Katsuhisa Ikeda5
1Department of Otorhinolaryngology, Juntendo University of Medicine, Shizuoka Hospital, Tokyo, Japan.
Frontiers in Immunology
|July 3, 2026
Summary
Chronic rhinosinusitis with eosinophilia (ECRS) involves inflammation and mucus. Antioxidants offer potential new treatments by targeting oxidative stress and inflammation pathways in this refractory condition.
Area of Science:
- Immunology
- Molecular Biology
- Pathophysiology
Background:
- Chronic rhinosinusitis with eosinophilia (ECRS) is a severe form of sinusitis with nasal polyps, olfactory dysfunction, and asthma.
- ECRS significantly impacts quality of life due to persistent congestion, discharge, and related symptoms like insomnia.
- Previous research links Cu,Zn-SOD defects to increased IL-17A and MUC5AC, and reduced HO-1 to epithelial damage in ECRS.
Purpose of the Study:
- To develop comprehensive molecular signaling pathway networks for oxidative stress, inflammation, and inflammation inhibition in ECRS.
- To create novel immunology flowsheets detailing oxidative stress and inflammation inhibition mechanisms in ECRS.
- To identify potential therapeutic targets for ECRS based on elucidated pathways.
Main Methods:
- Literature analysis to construct molecular signaling pathway networks.
- Development of immunology flowsheets for clinical and biochemical examination.
- Identification of treatment targets based on pathway analysis.
Main Results:
- Established three novel molecular signaling pathway networks: oxidative stress, inflammation inhibition, and inflammation in ECRS.
- Generated three immunology flowsheets illustrating key mechanisms.
- Identified specific molecular targets for future ECRS therapeutic strategies.
Conclusions:
- Antioxidants are crucial for understanding ECRS pathophysiology and developing new treatments.
- The developed pathways and flowsheets provide a comprehensive view of ECRS molecular mechanisms.
- This study offers a foundation for novel therapeutic interventions targeting ECRS.
